James T Dalton

USPTO Granted Patents = 101 (Patent Applications = 20)

CIPO Patents = 16 (Patent Applications = 5)

EPO Patents = 24 (Patent Applications = 30)

Average Co-Inventor Count = 4.0

ph-index = 22

Forward Citations = 1,630(Granted Patents)

Forward Citations (Not Self Cited) = 683(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Memphis, TN (US) (2000 - 2002)
Arlington, OH (US) (2010)
Columbus, OH (US) (2002 - 2013)
Upper Arlington, OH (US) (2006 - 2017)
Lakeland, TN (US) (2011 - 2022)
Ann Arbor, MI (US) (2016 - 2024)

Company Filing History:

78 out of 764

University of Tennessee Research Foundation

Oncternal Therapeutics, Inc.

patents

4. 5 out of 827

The Ohio State University

patents

5. 1 out of 891

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

Areas of Expertise:

Selective Androgen Receptor Degrader

Selective Androgen Receptor Modulator

Cancer Treatment

Breast Cancer Therapy

Nuclear Receptor Binding Agents

Estrogen Receptor Ligands

SARMs

Hormone-Related Conditions

Androgen Decline Treatment

Solid Forms of Selective Androgen Receptor Modulators

Non-Invasive Cancer Evaluation

Compounds for Cancer Treatment

101 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12128026 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2024-10-29),

2. 12115146 - Treatment of skeletal-related events for breast cancer patients (2024-10-15),

3. 12053448 - Solid forms of selective androgen receptor modulators (2024-08-06),

4. 11591290 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2023-02-28),

5. 11465987 - Compounds for treatment of cancer (2022-10-11),

6. 11273147 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2022-03-15),

7. 11090283 - Solid forms of selective androgen receptor modulators (2021-08-17),

8. 11084811 - Compounds for treatment of cancer (2021-08-10),

9. 10865196 - Compounds for treatment of cancer (2020-12-15),

10. 10849873 - Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy (2020-12-01),

11. 10662148 - Selective androgen receptor modulator and methods of use thereof (2020-05-26),

12. 10597354 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2020-03-24),

13. 10441570 - Selective androgen receptor degrader (SARD) Ligands and methods of use thereof (2019-10-15),

14. 10314807 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-06-11),

15. 10301285 - Compounds for treatment of cancer (2019-05-28),

Title: The Innovative Journey of James T. Dalton

Introduction: James T. Dalton, a pioneering inventor hailing from Lakeland, Tennessee, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: James T. Dalton holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on advancements in renewable energy solutions and sustainable packaging materials.

Career Highlights: Throughout his illustrious career, James T. Dalton has been recognized for his inventive spirit and problem-solving abilities. His inventions have not only improved efficiency in industries but have also positively impacted the environment.

Collaborations: James T. Dalton has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His partnerships have led to the development of cutting-edge technologies that have revolutionized the way we live and work.

Conclusion: In conclusion, James T. Dalton stands as a beacon of innovation, constantly pushing the boundaries of what is possible through his inventive mindset and dedication to creating a better future for all. His legacy as an inventor continues to inspire generations to come.

This text is generated by artificial intelligence and may not be accurate.